InMed Announces Publication of Study on Anti-Inflammation by Modulation of Endocannabinoid System

newsfile11/19 20:30

InMed Pharmaceuticals Shares Are Trading Lower After the Company Reported a Year-over-year Decrease in Q4 EPS Results.

Benzinga11/15 21:41

InMed Pharmaceuticals GAAP EPS of -$2.17, Revenue of $1.26M

Seeking Alpha11/15 06:44

Earnings Flash (INM) INMED PHARMACEUTICALS Reports Q1 Revenue $1.3M

MT Newswires11/15 05:47

InMed Reports First Quarter Fiscal 2025 Financial Results and Provides Business Update

newsfile11/15 05:45

インメッド・ファーマシューティカルズ | 10-Q：Q1 2025 四半期報告書

SEC11/15 05:22